Newsroom
Sorted by: Latest
-
GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is providing access to self-pay pricing for Novo Nordisk’s Ozempic® pill (oral semaglutide), helping eligible patients with type 2 diabetes obtain the medication for as low as $149 per month at pharmacies nationwide. “As Novo Nordisk brings the Ozempic pill to market, we’re focused on helping patients access it with clear, transparent pricing,” said We...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NYSE Arca Biotechnology UCITS ETF 30.04.2026 FBTU.LN IE00BL0L0H60 475,002.00 USD 11,912,413.43 25.079 ...
-
Canadian Public Relations Society (CPRS) Toronto Announces Winners of the 2026 ACE Awards
TORONTO--(BUSINESS WIRE)--The Canadian Public Relations Society (CPRS) Toronto Chapter has announced the winners of the 2026 annual ACE Awards. The awards celebrate the industry’s top communicators and public relations programs and campaigns from the past year. The ACE Awards Gala was held last night at The Carlu in Toronto. A total of 42 gold, 47 silver, and 41 bronze trophies were presented to a variety of PR professionals, agencies, corporations, students and not-for-profits from the Greater...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - June 30.04.2026 QJUN.LN IE000HFBJ0U0 3,700,002.00 USD 82,749,537.43 22.365 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Capital Strength UCITS ETF 30.04.2026 FTCS. IE00BL0L0D23 325,002.00 USD 10,610,911.74 32.649 ...
-
Quantum to Participate at the Needham Technology, Media & Consumer Conference on May 14
CENTENNIAL, Colo.--(BUSINESS WIRE)--Quantum Corporation (NASDAQ: QMCO), today announced that Hugues Meyrath, CEO, and William White, CFO, will participate at the Needham Technology, Media & Consumer Conference, which will be held as a virtual event on May 14, 2026. Management will be available to host scheduled conference calls with participating investors throughout the day. Portfolio managers and analysts who would like to request a meeting with management should contact their Needham &am...
-
Northisle Announces the Passing of Chairman Dale Corman
VANCOUVER, British Columbia--(BUSINESS WIRE)--Northisle is saddened to announce the passing of its Chairman, Dale Corman....
-
Nebius Group Announces Date of First Quarter 2026 Results and Conference Call
AMSTERDAM--(BUSINESS WIRE)--Nebius Group N.V. (“Nebius Group” or the “Company”; NASDAQ: NBIS), will release its first quarter 2026 financial results on Wednesday, May 13, 2026, before market open. Nebius Group will also hold a conference call to discuss its results at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time / 2:00 p.m. Central European Time) on the same day. The registration link to access the webcast and its replay will be available on Nebius Group’s Investor Relations website at https:...
-
The ONE Group Hospitality, Inc. to Host First Quarter 2026 Earnings Conference Call and Webcast at 4:30 PM ET on May 6, 2026
DENVER--(BUSINESS WIRE)--The ONE Group Hospitality, Inc. (“The ONE Group” or the “Company”) (Nasdaq: STKS) today announced that Emanuel “Manny” Hilario, President and Chief Executive Officer, and Nicole Thaung, Chief Financial Officer, will host a conference call and webcast to discuss first quarter 2026 financial results on Wednesday, May 6, 2026, at 4:30 PM ET. A press release containing the first quarter 2026 financial results will be issued after market close that same afternoon. The confer...
-
TaeWoong Medical USA Receives FDA 510(k) Clearance for SPAXUS™, Expanding Its EUS Therapeutic Portfolio
LOS ANGELES--(BUSINESS WIRE)--TaeWoong Medical USA today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Niti-S SPAXUS™ Stent, further strengthening its portfolio of endoscopic ultrasound (EUS)-guided therapeutic solutions. The FDA determined the SPAXUS™ Stent to be substantially equivalent to legally marketed predicate devices, allowing for commercialization in the United States. SPAXUS™ is a fully covered, self-expanding metallic stent designed to fa...